Global Thin Film Drug Manufacturing Market Size To Worth USD 27.17 Billion By 2033 | CAGR OF 10.71%
Category: HealthcareGlobal Thin Film Drug Manufacturing Market Size To Worth USD 27.17 Billion By 2033
According to a research report published by Spherical Insights & Consulting, the Global Thin Film Drug Manufacturing Market Size is Expected to Grow from USD 9.82 Billion in 2023 to USD 27.17 Billion by 2033, at a CAGR of 10.71% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 215 pages with 110 Market data tables and figures & charts from the report on the "Global Thin Film Drug Manufacturing Market Size, Share, and COVID-19 Impact Analysis, By Product (Oral Thin Film, Transdermal Thin Film, and Others), By Indication (Schizophrenia, Migraine, and Opioid Dependence), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here : https://www.sphericalinsights.com/reports/thin-film-drug-manufacturing-market
A new method of drug delivery involves the use of thin, flexible films or oral drug strips to administer medications, known as thin film drugs. These drugs dissolve rapidly in the mouth, allowing active ingredients to enter the bloodstream through the buccal membranes in the cheeks and can also be absorbed in the small intestines. Thin film drugs are effective in treating various conditions such as nausea, pain, cough, cold, motion sickness, bronchitis, asthma, and more, and are suitable for pediatric, geriatric, and psychiatric patients. They provide a convenient and easy administration method, particularly beneficial for individuals with mobility issues or those constantly on the move, and also offer a discreet and non-invasive way to take medication. There are various factors that drive the market; one of the factors is advancements in this novel drug delivery. Various companies around the globe are focusing on investment in this promising form of drug delivery owing to a rise in recognition. Key start-up companies are particularly focusing on thin-film drug delivery routes for cannabis-based drugs. Additionally, the rise in the regulatory approvals for thin film drugs for various disease indications is propelling the growth of the market. The rising acceptance of thin-film therapeutics among the older population of the world is increasing due to the ease of administration of such therapeutics. However, there are numerous factors that can restrain the thin film drug manufacturing market, including. The complex manufacturing processes for oral thin films involve advanced equipment, expertise, and quality control. The cost and complexity of manufacturing can bind the availability and affordability of oral thin films. Oral thin films can only carry a small medication load of 10 to 20 mg. Oral thin films are more vulnerable to humidity and temperature due to their larger surface area. The high cost of developing thin-film drugs limits research and implementation in developing countries.
The oral thin film segment is predicted to hold the largest market share through the forecast period.
Based on the product, the thin film drug manufacturing market is classified into oral thin film, transdermal thin film, and others. Among these, the oral thin film segment is predicted to hold the largest market share through the forecast period. The innovative delivery method of oral thin film films enhances patient compliance and convenience due to their quick dissolution on the tongue, allowing for rapid absorption of active ingredients. This benefit is particularly valuable for patients who struggle to swallow pills or need fast-acting medications. Furthermore, advancements in formulation technologies improve the taste and stability of these films, making them more appealing to consumers. As healthcare trends prioritize patient-centric solutions and non-invasive administration methods, the demand for oral thin films is expected to significantly increase in the projected period.
The schizophrenia segment is anticipated to hold the highest market share during the projected timeframe.
Based on the indication, the thin film drug manufacturing market is divided into schizophrenia, migraine, and opioid dependence. Among these, the schizophrenia segment is anticipated to hold the highest market share during the projected timeframe. This is driven by the disorder's increasing prevalence and the growing awareness of mental health issues. As research progresses and new treatment options emerge, there is a heightened focus on innovative therapies, including atypical antipsychotics and long-acting injectables, which improve patient adherence and outcomes. Additionally, the rising investments in mental health initiatives and the destigmatization of mental illness are leading to more patients seeking treatment, making the schizophrenia segment a significant focus for pharmaceutical companies and healthcare providers alike.
North America is estimated to hold the largest share of the thin film drug manufacturing market over the forecast period.
Get more details on this report -
North America is estimated to hold the largest share of the thin film drug manufacturing market over the forecast period. North America benefits from a robust healthcare infrastructure, significant investment in research and development, and a strong presence of leading pharmaceutical companies. The rising prevalence of chronic diseases and a growing emphasis on patient-centric drug delivery systems are driving demand for innovative formulations like oral thin films. Regulatory support and a favorable reimbursement landscape further enhance market growth, positioning North America as a critical hub for advancements in thin film drug technology, allowing the region to lead the market throughout the forecast period.
Asia Pacific is expected to grow the fastest during the forecast period. The region experiences a surge in chronic diseases, which drives the need for innovative treatment options that enhance patient compliance, such as oral thin films, due to a combination of rapidly expanding healthcare infrastructure, increasing investments in pharmaceutical research, and rising demand for advanced drug delivery systems. Additionally, growing awareness of mental health issues and the adoption of modern therapeutic approaches contribute to market expansion. The presence of a large population, coupled with rising disposable incomes and improving access to healthcare services, positions Asia Pacific as a dynamic and promising market for thin film drug manufacturing.
Major key players in the thin film drug manufacturing market include Pfizer, Inc., Novartis AG, Wolters Kluwer, Solvay, AbbVie, Sumitomo Pharma Co., Ltd, IntelGenx Corp., NAL Pharma, ZIM Laboratories Limited, Indivior PLC, MonoSol and Others.
Recent Developments
- In August 2024, atai Life Sciences which is a clinical-stage biopharmaceutical company with the goal of revolutionizing the treatment of mental health disorders, reported encouraging initial findings from the Phase 1b study of VLS-01, its specialized oral transmucosal film containing N, N-dimethyltryptamine (DMT) that is administered on the buccal surface.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the thin film drug manufacturing market based on the below-mentioned segments:
Global Thin Film Drug Manufacturing Market, By Product
- Oral Thin Film
- Transdermal Thin Film
- Others
Global Thin Film Drug Manufacturing Market, By Indication
- Schizophrenia
- Migraine
- Opioid Dependence
Global Thin Film Drug Manufacturing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?